Andrew Lo is Director of AbCellera Biologics Inc.. Currently has a direct ownership of 86,938 shares of ABCL, which is worth approximately $237,340. The most recent transaction as insider was on Dec 03, 2021, when has been sold 86,938 shares (Share Option (right to buy)) at a price of $14.02 per share, resulting in proceeds of $1,218,871. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.9K
0% 3M change
0% 12M change
Total Value Held $237,340

Andrew Lo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 03 2021
BUY
Open market or private purchase
$1,218,871 $14.02 p/Share
86,938 Added 50.0%
86,938 Share Option (right to...

Also insider at

BBIO
BridgeBio Pharma, Inc. Healthcare
ROIV
Roivant Sciences Ltd. Healthcare
AL

Andrew Lo

Director
London, X0

Track Institutional and Insider Activities on ABCL

Follow AbCellera Biologics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABCL shares.

Notify only if

Insider Trading

Get notified when an Ab Cellera Biologics Inc. insider buys or sells ABCL shares.

Notify only if

News

Receive news related to AbCellera Biologics Inc.

Track Activities on ABCL